Phio Pharmaceuticals Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Phio Pharmaceuticals Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 990K shares, a 265% increase year-over-year.
  • Phio Pharmaceuticals Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.08M shares, a 83.3% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.14M shares, a 6.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 990K +719K +265% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 510K +318K +166% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.58M +3.44M +301% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.08M +947K +83.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 271K -867K -76.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 192K -946K -83.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.14M +11.9K +1.05% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 1.14M +67.3K +6.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 1.14M -12.4M -91.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.14M -12.4M -91.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 1.13M -9.55M -89.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 1.07M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 13.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 13.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 10.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.